Mouse Study Transplants Neurons to Rebuild Brain Circuits
Neuron transplants have repaired brain circuitry and substantially normalized function in mice with a brain disorder, indicating that key areas of the brain are more repairable than was widely believed, according to new research.
Collaborators from four institutions — Harvard University, Massachusetts General Hospital, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School (HMS) — transplanted normally functioning embryonic neurons at a carefully selected stage of their development into the hypothalamus of mice unable to respond to leptin, a hormone that regulates metabolism and controls body weight.
These mutant mice usually become morbidly obese, but the neuron transplants repaired defective brain circuits, enabling them to respond to leptin and gain much less weight.
Repair at the cellular level of the hypothalamus — a critical and complex region of the brain that regulates phenomena such as hunger, metabolism, body temperature, and basic behaviors such as sex and aggression — indicates the possibility of new therapeutic approaches to conditions such as spinal cord injury, autism, epilepsy, ALS (Lou Gehrig’s disease), Parkinson’s disease, and Huntington’s disease, researchers said.
“There are only two areas of the brain that are known to normally undergo ongoing large-scale neuronal replacement during adulthood on a cellular level — so-called ‘neurogenesis’ or the birth of new neurons — the olfactory bulb and the subregion of the hippocampus called the dentate gyrus, with emerging evidence of lower level ongoing neurogenesis in the hypothalamus,” said Jeffrey Macklis, M.D., Harvard University professor of stem cell and regenerative biology.
“The neurons that are added during adulthood in both regions are generally smallish and are thought to act a bit like volume controls over specific signaling. Here we’ve rewired a high-level system of brain circuitry that does not naturally experience neurogenesis, and this restored substantially normal function.”
The two other authors on the paper are Jeffrey Flier, dean of Harvard Medical School, and Matthew Anderson, HMS professor of pathology at Beth Israel.
In 2005, Flier published a study showing that an experimental drug spurred the addition of new neurons in the hypothalamus and offered a potential treatment for obesity.
But while the finding was striking, the researchers were unsure whether the new cells functioned like natural neurons.
Macklis’s laboratory had developed approaches to transplanting developing neurons into circuitry of the cerebral cortex of mice with neurodegeneration or neuronal injury. In a 2000 study, the researchers demonstrated induction of neurogenesis in the cerebral cortex of adult mice, where it does not normally occur. While these and followup experiments appeared to rebuild brain circuitry anatomically, the new neurons’ level of function remained uncertain.
To learn more, Flier, an expert in the biology of obesity, teamed up with Macklis, an expert in central nervous system development and repair, and Anderson, an expert in neuronal circuitries and mouse neurological disease models.
The researchers used a mouse model in which the brain lacks the ability to respond to leptin. Flier and his lab have long studied this hormone, which is mediated by the hypothalamus. Deaf to leptin’s signaling, these mice become dangerously overweight.
Prior research had suggested that four main classes of neurons enabled the brain to process leptin signaling. Researchers transplanted and studied the cellular development and integration of progenitor cells and very immature neurons from normal embryos into the hypothalamus of the mutant mice, using multiple types of cellular and molecular analysis.
To place the transplanted cells in exactly the right region of the hypothalamus, they used a technique called high-resolution ultrasound microscopy, creating what Macklis called a “chimeric hypothalamus”— like the animals with mixed features from Greek mythology.
Researchers then performed in-depth electrophysiological analysis of the transplanted neurons and their function in the recipient circuitry, taking advantage of the neurons glowing green from a fluorescent jellyfish protein carried as a marker.
These nascent neurons survived the transplantation process and developed structurally, molecularly, and electrophysiologically into the four types of neurons central to leptin signaling. The new neurons integrated functionally into the circuitry, responding to leptin, insulin, and glucose. Treated mice matured and weighed approximately 30 percent less than their untreated siblings or siblings treated in multiple alternate ways.
The researchers then investigated the extent to which these new neurons had become wired into the brain’s circuitry using molecular assays, electron microscopy for visualizing the details of circuits, and patch-clamp electrophysiology, a technique in which researchers use small electrodes to investigate the characteristics of individual neurons and pairs of neurons in fine detail. Because the new cells were labeled with fluorescent tags, researchers could easily locate them.
The researchers found that the newly developed neurons communicated to recipient neurons through normal synaptic contacts, and that the brain, in turn, signaled back. Responding to leptin, insulin and glucose, these neurons had effectively joined the brain’s network and rewired the damaged circuitry.
“It’s interesting to note that these embryonic neurons were wired in with less precision than one might think,” Flier said. “But that didn’t seem to matter. In a sense, these neurons are like antennas that were immediately able to pick up the leptin signal. From an energy-balance perspective, I’m struck that a relatively small number of genetically normal neurons can so efficiently repair the circuitry.”
“The finding that these embryonic cells are so efficient at integrating with the native neuronal circuitry makes us quite excited about the possibility of applying similar techniques to other neurological and psychiatric diseases of particular interest to our laboratory,” said Anderson.
The researchers call their findings a proof of concept for the broader idea that new neurons can integrate specifically to modify complex circuits that are defective in a mammalian brain.
“The next step for us is to ask parallel questions of other parts of the brain and spinal cord, those involved in ALS and with spinal cord injuries,” Macklis said. “In these cases, can we rebuild circuitry in the mammalian brain? I suspect that we can.”
The new study was published in the journal Science.
Source: Harvard University
Wood, J. (2011). Mouse Study Transplants Neurons to Rebuild Brain Circuits. Psych Central. Retrieved on July 1, 2015, from http://psychcentral.com/news/2011/11/29/mouse-study-transplants-neurons-to-rebuild-brain-circuits/31975.html